INDP - Indaptus Therapeutics, Inc. News

Discover

INDP

Indaptus Therapeutics, Inc.

2.61

1 x 2.58

2 x 2.67

bid

ask

0.09

3.57%

12:01 PM

timesize

Ytd	-10.31%
1y	-75.88%

2.42

day range

2.62

0.92

52 week range

10.91

Open	2.42	Prev Close	2.52	Low	2.42	High	2.62	Mkt Cap	4.41M
Vol	6.18K	Avg Vol	1.01M	EPS	-15.40	P/E	-0.16	Forward P/E	-0.64
Beta	1.11	Short Ratio	0.54	Inst. Own	6.00%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	05-14	50-d Avg	2.55	200-d Avg	2.51	1yr Est	8.50

INDP News

globenewswire.com

Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders

STAMFORD, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating potential leg

benzinga.com

Ouster, Datavault AI, Paranovus Entertainment Technology And Other Big Stocks Moving Higher On Monda

U.S. stocks higher with Nasdaq up 2%. Ouster shares rise 15.8%, PAVS gains 92.1%. Other big gains in

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com

Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-m

benzinga.com

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com

Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket

Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing

benzinga.com

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com

Earnings Scheduled For May 15, 2026

globenewswire.com

Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or

benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

defenseworld.net

Comparing Indaptus Therapeutics (NASDAQ:INDP) & Aldeyra Therapeutics (NASDAQ:ALDX)

Aldeyra Therapeutics (NASDAQ: ALDX - Get Free Report) and Indaptus Therapeutics (NASDAQ: INDP - Get

defenseworld.net

Indaptus Therapeutics (INDP) Expected to Announce Quarterly Earnings on Thursday

Indaptus Therapeutics (NASDAQ: INDP - Get Free Report) is expected to be issuing its results before

benzinga.com

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session

globenewswire.com

Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” o

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com

Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket

globenewswire.com

Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” o

globenewswire.com

Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” o

defenseworld.net

Critical Review: Redhill Biopharma (NASDAQ:RDHL) and Indaptus Therapeutics (NASDAQ:INDP)

Redhill Biopharma (NASDAQ: RDHL - Get Free Report) and Indaptus Therapeutics (NASDAQ: INDP - Get Fre

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

globenewswire.com

Indaptus Therapeutics Provides Clinical Update

Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases

globenewswire.com

Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced to

globenewswire.com

Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Company Initiates Combination Trial and Strengthens Balance Sheet to Support Continued Clinical Prog

globenewswire.com

Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Conver

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”),

globenewswire.com

Indaptus Therapeutics Announces Reverse Stock Split

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” o

benzinga.com

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com

Why Sequans Communications Shares Are Trading Higher By Over 42%; Here Are 20 Stocks Moving Premarke

globenewswire.com

Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”),

globenewswire.com

Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Check

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-s

globenewswire.com

Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or

globenewswire.com

Indaptus Therapeutics Founder and Chief Scientific Officer Dr. Michael Newman Named Chair and Expert

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-st

globenewswire.com

Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-

globenewswire.com

Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in We

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-

globenewswire.com

Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-

benzinga.com

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 241 companies hit new 52-week lows.